PMID: 6403671May 1, 1983Paper

Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats

Journal of Neurochemistry
M E Trulson, C D Himmel

Abstract

The rate of accumulation of 3,4-dihydroxy-phenylalanine following decarboxylase inhibition and of homovanillic acid following probenecid treatment were significantly decreased in streptozotocin-diabetic rats. These changes were observed in both the striatum and limbic forebrain. The Bmax for [3H]spiroperidol receptor binding was significantly increased in both brain regions. All of these neurochemical changes were reversed by insulin replacement therapy. Whether these neurochemical changes are attributable to chronic hyperglycemia or some other aspect of the diabetic state is not known.

References

Feb 1, 1978·Neuropharmacology·R L Dorris
Jun 1, 1976·European Journal of Pharmacology·B H Westerink, J Korf
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·W KehrM Lindqvist
Oct 1, 1971·Diabetologia·M Hohenegger, B Rudas
Nov 27, 1981·Science·D LozovskyI J Kopin

❮ Previous
Next ❯

Citations

Jan 1, 1995·Journal of Neural Transmission. General Section·M SalkovićZ Lacković
Jan 10, 2009·Cellular and Molecular Neurobiology·Remya RobinsonC S Paulose
Jun 24, 1985·Brain Research·F K NorthingtonS P Banerjee
Jan 1, 1988·Life Sciences·J ManzanaresF Zaragozá
Apr 1, 1990·Physiology & Behavior·Y ShimomuraS Kobayashi
Jun 1, 1990·Physiology & Behavior·Y ShimomuraS Kobayashi
Dec 1, 1988·Pharmacology, Biochemistry, and Behavior·J MassolA J Puech
Feb 1, 1989·Pharmacology, Biochemistry, and Behavior·W T ChanceJ E Fischer
Jun 1, 1991·Pharmacology, Biochemistry, and Behavior·T Z GuoM Maze
Mar 1, 1993·Pharmacology, Biochemistry, and Behavior·J P Heaton, S J Varrin
Jul 1, 1988·Behavioural Brain Research·Z MeraliJ Veitch
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Lal
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·S LalB Dubrovsky
Aug 31, 1984·Neuroscience Letters·C F Saller
Jan 5, 1996·Neuroscience Letters·E MurziL Hernandez
Jan 1, 1989·Psychoneuroendocrinology·L J Leedom, W P Meehan
Jul 6, 2000·Pharmacology, Biochemistry, and Behavior·R Gomez, H M Barros
Jun 4, 1998·Pharmacology, Biochemistry, and Behavior·J KatajamäkiL Ahtee
Aug 13, 1998·Pharmacology, Biochemistry, and Behavior·N Takeshita, I Yamaguchi
Apr 1, 1992·British Journal of Pharmacology·P D MorrisonT W Stone
Dec 16, 2006·The Journal of Pharmacology and Experimental Therapeutics·Rajkumar J SevakCharles P France
Feb 24, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·W Anthony OwensLynette C Daws
Sep 1, 1988·Neurochemical Research·R P Kwok, A V Juorio
Jun 1, 1988·Neurochemical Research·J R Dyer, C E Greenwood
Feb 1, 1990·The International Journal of Neuroscience·R Sandyk
Mar 1, 1993·The International Journal of Neuroscience·R Sandyk
Jan 1, 1990·Journal of Neurochemistry·Z LackovićM Relja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.